Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5204642
Max Phase: Preclinical
Molecular Formula: C21H32O3
Molecular Weight: 332.48
Associated Items:
ID: ALA5204642
Max Phase: Preclinical
Molecular Formula: C21H32O3
Molecular Weight: 332.48
Associated Items:
Canonical SMILES: CC1(C)CCC[C@]2(C)[C@@H](Cc3cc(O)cc(O)c3)[C@](C)(O)CC[C@@H]12
Standard InChI: InChI=1S/C21H32O3/c1-19(2)7-5-8-20(3)17(19)6-9-21(4,24)18(20)12-14-10-15(22)13-16(23)11-14/h10-11,13,17-18,22-24H,5-9,12H2,1-4H3/t17-,18+,20-,21+/m0/s1
Standard InChI Key: QXFSMKJNJYLPQH-IZZBFERCSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 332.48 | Molecular Weight (Monoisotopic): 332.2351 | AlogP: 4.63 | #Rotatable Bonds: 2 |
Polar Surface Area: 60.69 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 9.35 | CX Basic pKa: | CX LogP: 4.78 | CX LogD: 4.78 |
Aromatic Rings: 1 | Heavy Atoms: 24 | QED Weighted: 0.74 | Np Likeness Score: 2.40 |
1. Wang X, Hu N, Kong W, Song B, Li S.. (2022) Facile and divergent optimization of chromazonarol enabled the identification of simplified drimane meroterpenoids as novel pharmaceutical leads., 227 [PMID:34653771] [10.1016/j.ejmech.2021.113912] |
Source(1):